UK markets closed
NIKKEI 225
38,236.07 -37.98 (-0.10%) HANG SENG
18,207.13 +444.10 (+2.50%) CRUDE OIL
79.03 +0.03 (+0.04%) GOLD FUTURES
2,315.90 +4.90 (+0.21%) DOW
38,186.95 +283.66 (+0.75%) Bitcoin GBP
47,166.27 +1,149.58 (+2.50%)
JAZZ Dec 2024 160.000 call
OPR - OPR Delayed price. Currency in USD
Add to watchlist
As of 11:15AM EDT. Market open.
| Previous close | 3.5000 |
| Open | 4.5000 |
| Bid | 0.2000 |
| Ask | 3.5000 |
| Strike | 160.00 |
| Expiry date | 2024-12-20 |
| Day's range | 3.5000 - 3.5000 |
| Contract range | N/A |
| Volume | |
| Open interest | 5 |
ZacksJazz (JAZZ) Q1 Earnings: Taking a Look at Key Metrics Versus Estimates
The headline numbers for Jazz (JAZZ) give insight into how the company performed in the quarter ended March 2024, but it may be worthwhile to compare some of its key metrics to Wall Street estimates and the year-ago actuals.
PR NewswireJazz Pharmaceuticals to Participate in the BofA Securities 2024 Health Care Conference
Jazz Pharmaceuticals plc (Nasdaq: JAZZ) today announced that Company management will participate in the BofA Securities 2024 Global Health Care Conference on Wednesday, May 15, 2024, in Las Vegas. The fireside chat will be held at 10:00 a.m. PT / 1:00 p.m. ET / 6:00 p.m. IST.
- PR Newswire
Jazz Pharmaceuticals Announces First Quarter 2024 Financial Results and Affirms 2024 Financial Guidance
Jazz Pharmaceuticals plc (Nasdaq: JAZZ) today announced financial results for the first quarter of 2024 and affirmed guidance for 2024.
© 2024 Yahoo. All rights reserved.